5 advancements in kidney disease research over the past year
Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like…
Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like…
Confo Therapeutics, which works on the discovery of medicines targeting G-protein coupled receptors (GPCRs), has…
Sosei Group Corporation has entered a drug discovery collaboration with Eli Lilly and Company to…
Jacobio announced it has entered into a clinical trial collaboration agreement with Merck on a…
A phase 3 clinical trial for an injection to treat patients with schizophrenia has been…
This week our guests on the podcast are Xianghao Zuo, deputy director of R&D at…
Eli Lilly and Company is boosting its manufacturing footprint by investing $2.1 billion in two…
Eli Lilly will partner Oxford-based Sitryx to develop up to four drug candidates to treat…
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
Update (30/09/2019): A long legal battle between Adocia and Eli Lilly over a fast-acting insulin…
AC Immune will receive €27.6M (CHF 30M) from big pharma Eli Lilly as it begins…
In the midst of a legal litigation with Eli Lilly, Adocia has released Phase 1…